Predicted Coronary Heart Disease Risk Decreases in Obese Patients After Laparoscopic Sleeve Gastrectomy

Huang, Cheng Chiao; Wang, Weu; Chen, Ray Jade; Wei, Po Li; Tzao, Ching; Chen, Ping Ling

doi:10.1007/s00268-017-4416-6

Cited by 14 publications

(3 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thus early bariatric intervention for the high-risk groups is strongly recommended by the authors. 10 Our patients did not have increased risk of coronary heart disease but three of our patients had a significant improvement in serum cholesterol and triglyceride levels 6months postoperatively. As far as glycemic control and diabetes are concerned, data for benefits after sleeve gastrectomy are still conflicting, suggesting the need for further studies.…”

Section: Effects Of Sleeve Gastrectomymentioning

confidence: 51%

Concerns during Initiation of Sleeve Gastrectomy in a Laparoscopic Bariatric Program: A Single Surgeon’s Initial Experience and Review of Latest Literature

Hirides¹,

Hirides²

2018

AOWMC

View full text Add to dashboard Cite

Introduction: Among the existing weight-loss procedures, laparoscopic sleeve gastrectomy has gained increasing popularity in the past decade, due to its remarkable results concerning EWL and resolution of comorbidities. However, most of major concerns for a team initiating with sleeve gastrectomy, still remain as subjects of major controversy among authors. Aim: to present a single surgeon's technique and initial results with laparoscopic sleeve gastrectomy and review the latest literature for main concerns of a novice team. Material: Six patients aged 24-49years, underwent full preoperative workup, including history, physical examination, evaluation from cardiologist, anesthesiologist, as well as clinical dietician and pneumologist. A laparoscopic sleeve gastrectomy was offered as the most suitable bariatric procedure for 5 of the patients. One of the patients underwent a robotic-assisted technique. Results: All 6 patients followed an uncomplicated course. All patients were assessed for leaks on postoperative day 2 by gastrographin swallow. One patient presented with high fever on postoperative day 4 and was readmitted. No leaks were noted in any of the patients. Conclusion: Reinforcing the staple line during sleeve gastrectomy by suturing and glue is the routine followed by the authors. Robotics seem to facilitate sleeve gastrectomy, especially during challenging mobilization of the fundus near the spleen as well as during intracorporeal suturing. Advances in Obesity Weight Management & Control Research Article Open Access Concerns during initiation of sleeve gastrectomy in a laparoscopic bariatric program: a single surgeon's initial experience and review of latest literature 18 Copyright: ©2018 Hirides et al.

show abstract

Section: Effects Of Sleeve Gastrectomymentioning

confidence: 51%

Concerns during Initiation of Sleeve Gastrectomy in a Laparoscopic Bariatric Program: A Single Surgeon’s Initial Experience and Review of Latest Literature

Hirides¹,

Hirides²

2018

AOWMC

View full text Add to dashboard Cite

show abstract

“…When compared with the study population of Blanco et al was reported [26]. Second, there were differences in the calculation methods of the risk scores.…”

Section: Discussionmentioning

confidence: 97%

“…In addition, studies on which kind of bariatric surgery would be more beneficial in improving the CVD score are rare. Several studies reported that laparoscopic Roux-en Y gastric bypass (LRYGB), laparoscopic sleeve gastrectomy (LSG), and laparoscopic adjustable gastric banding reduced the CVD risk score; however, most of them were noncomparative studies [12,[24][25][26] and only few studies directly compared LSG and LRYGB [13][14][15]27].…”

Section: Introductionmentioning

confidence: 99%

Impact of Bariatric Surgery on Cardiovascular Risk Reduction in Korean Obese Patients

Jeon

Kim

et al. 2019

J Metab Bariatr Surg

View full text Add to dashboard Cite

Purpose: Morbid obesity is a well-known risk factor for cardiovascular disease (CVD). This study aimed to quantitatively evaluate the effects of bariatric surgery on CVD risk reduction in Korean obese patients by using three CVD risk prediction models (Framingham General Cardiovascular Risk Score [FRS], Pooled Cohort Equation [PCE], and Korean Risk Prediction Model [KRPM]), and to investigate which procedure between laparoscopic Roux-en Y gastric bypass (LRYGB) and laparoscopic sleeve gastrectomy (LSG) is a better option for CVD risk reduction. Materials and Methods: We retrospectively reviewed all obese patients who underwent bariatric surgery at a single institution from October 2009 to May 2016. Of the 1034 patients reviewed, 83 patients (6.5%) who met the criteria for calculating the FRS, PCE, and KRPM scores and had a follow-up of at least 1 year were included in this study. Results: The FRS, PCE, and KRPM scores were significantly decreased at postoperative 1 year (10.47±7.30% to 6.33±4.

show abstract

Favorable electrocardiographic changes after substantial weight loss in patients with morbid obesity

Gül

İnci

Özkan

et al. 2021

Herz

View full text Add to dashboard Cite

Predicted Coronary Heart Disease Risk Decreases in Obese Patients After Laparoscopic Sleeve Gastrectomy

Abstract: Laparoscopic sleeve gastrectomy is efficient not only in the reduction of obesity and its related comorbidities but also in decreasing the long-term coronary event risk. Early intervention for the high-risk group is strongly recommended.

Cited by 14 publications

References 34 publications

Concerns during Initiation of Sleeve Gastrectomy in a Laparoscopic Bariatric Program: A Single Surgeon’s Initial Experience and Review of Latest Literature

Concerns during Initiation of Sleeve Gastrectomy in a Laparoscopic Bariatric Program: A Single Surgeon’s Initial Experience and Review of Latest Literature

Impact of Bariatric Surgery on Cardiovascular Risk Reduction in Korean Obese Patients

Favorable electrocardiographic changes after substantial weight loss in patients with morbid obesity

Contact Info

Product

Resources

About